Copyright License
IJCY publishes all articles under a clear open access license that supports global reuse while protecting author attribution.
Authors retain copyright and grant the journal the right to publish and distribute the final version.
Why Researchers Trust Us
Fast Publication
Average 4 weeks to first decision, 3 weeks to publication after acceptance
Expert Review
35+ editorial board members specializing in cytokine biology and immunology
Global Reach
Research disseminated to immunology professionals in 45+ countries immediately
Rigorous Standards
Double-blind peer review ensuring highest scientific quality and reproducibility
Journal at a Glance
International Journal of Cytokine publishes research that advances understanding of immune signaling, inflammation, and translational immunology. The journal emphasizes rigorous methodology, clear reporting, and clinical relevance to support evidence based care.
Our publishing model combines rapid editorial triage with expert peer review so that cytokine research can move from discovery to application efficiently.
- Peer reviewed open access journal focused on cytokine science.
- Double blind peer review and structured editorial decisions.
- DOI assignment and metadata delivery for discoverability.
- Global readership across immunology and clinical communities.
Quality and Transparency Commitment
Quality assurance is embedded throughout the IJCY workflow. Editorial screening, ethical checks, and reviewer guidance ensure that published results are credible, reproducible, and clinically meaningful.
Authors receive clear decision letters and detailed revision guidance, helping them improve manuscripts and communicate findings with precision.
- Structured reviewer criteria and decision templates.
- Integrity checks for originality and data clarity.
- Transparent timelines and consistent communication.
License Overview
Articles are published under the Creative Commons Attribution 4.0 International license. This license allows sharing and adaptation for any purpose when proper credit is given.
The model improves access to cytokine research for clinicians, educators, and policy teams.
What Authors Retain
Copyright Ownership
Authors keep copyright and retain long term control of their work.
Reuse Rights
Figures and text may be reused in future publications and teaching.
Repository Sharing
Authors may deposit the final PDF in institutional or subject repositories.
Third Party Control
Permissions for third party content remain with the author.
Reuse Under CC BY 4.0
Readers may copy, translate, and build upon the work with proper attribution. Changes must be indicated and no additional restrictions may be applied beyond the license terms.
- Credit authors, journal name, year, and DOI.
- Indicate modifications or translations.
- Maintain citation and attribution integrity.
Recommended Attribution Format
A simple attribution format is: Author(s). Article title. International Journal of Cytokine, year, DOI. Licensed under CC BY 4.0.
Consistent attribution helps track citations and ensures that authors receive proper credit for their work.
Common Reuse Scenarios
CC BY 4.0 enables reuse in education, policy, and clinical practice when attribution is provided.
These reuse pathways help cytokine findings move into real world application faster.
- Reuse figures in clinical guidelines or presentations.
- Include data tables in systematic reviews.
- Translate summaries for regional outreach programs.
License Boundaries
The license does not allow misrepresentation or removal of attribution. Reusers must avoid implying author endorsement and should disclose any modifications.
For human participant data, privacy and consent requirements remain in effect regardless of license.
Contact the editorial office if reuse questions arise.
License FAQ
Authors often ask how the license affects reuse in teaching, grants, and clinical materials. The CC BY 4.0 license is designed to enable broad reuse while preserving attribution.
When in doubt, contact the editorial office for guidance on appropriate attribution.
Clear reuse guidance protects author credit and avoids misinterpretation.
- Authors may post the final PDF on lab or institutional websites.
- Figures can be reused in grant proposals with citation.
- Commercial reuse is allowed when attribution is provided.
Third Party Content
If manuscripts contain third party figures or licensed tools, authors must secure permission and clearly label any restrictions on reuse.
- Provide permissions during submission.
- Identify any content excluded from CC BY 4.0.
- Keep documentation for editorial review.
Compliance and Sharing
The CC BY 4.0 license supports most funder open access requirements. Authors may share the final version immediately after publication using the DOI link.
Clear licensing improves discoverability and supports reuse in guidelines, clinical practice, and education.
Include the DOI in all shared copies to maintain accurate citation tracking.
Consistent sharing practices help maintain a reliable scholarly record.
This supports consistent indexing across platforms and repositories.
License Questions
Copyright and Permissions
Email the editorial office with licensing questions or reuse requests.
[email protected]
